Albireo Pharma Inc (NASDAQ:ALBO)

Delayed Data
As of Mar 16
 +2.86 / +7.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 63.00, with a high estimate of 92.00 and a low estimate of 47.00. The median estimate represents a +60.10% increase from the last price of 39.35.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -31.00%
Growthannually 3.92%


Growthquarterly --
Growthannually 1,243,150.00%
Key to the earnings and sales forecast charts.